combretastatin has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billard, C; Combes, S; Faussat, AM; Finet, JP; Kolb, JP; Menasria, F; Quiney, C | 1 |
1 other study(ies) available for combretastatin and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
4-arylcoumarin analogues of combretastatins stimulate apoptosis of leukemic cells from chronic lymphocytic leukemia patients.
Topics: Aged; Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Bibenzyls; Caspase 3; Caspase Inhibitors; Cyclin-Dependent Kinase Inhibitor p27; Cysteine Proteinase Inhibitors; DNA Fragmentation; Drug Screening Assays, Antitumor; Enzyme Activation; Female; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2008 |